Clinical Trial Update: Ischemia Driven Enoxaparin Therapy in ACS Presenting as Low Risk (IDEAL) [Phase 4]

View source ↗

Summary

IDEAL is a Phase 4 trial evaluating ischemia-driven enoxaparin therapy in acute coronary syndrome presenting as low risk. The study focuses on unstable angina a…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome
• Unstable Angina

Drugs mentioned

• Lovenox (enoxaparin) (enoxaparin)

Snippet

Sponsor: Canadian Heart Research Centre | Conditions: Unstable Angina | Phase 4 | Status: TERMINATED